Jefferies Reiterates a 'Buy' on Express Scripts (ESRX); Still Bullish

Jefferies reiterates a 'Buy' on Express Scripts (NASDAQ: ESRX) price target of $70.00 (from $68.00).

Analyst, Brian Tanquilut, said, "We remain very bullish on ESRX despite the stock's recent run to $60 given our belief that net Medco synergies will come even sooner than mgmt's updated timeline and will most likely exceed their $1 billion guidance. We believe this earnings power will enable mgmt to issue above-consensus FY13 EPS guidance in November that will provide an incremental lift to ESRX shares."

For an analyst ratings summary and ratings history on Express Scripts click here. For more ratings news on Express Scripts click here.

Shares of Express Scripts closed at $60.71 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Piper Sandler Reiterates Overweight Rating on KKR (KKR), 'highest conviction name'
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c